Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Remote ischemic conditioning wikipedia , lookup
Coronary artery disease wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Heart failure wikipedia , lookup
Jatene procedure wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
AUTOIMMUNE RESPONSE TO BACTERIAL ANTIGENS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION Dielievska V. YU, Khilko M.S. Scientific advisor: d.med.sciences, prof. Kravchun P.G. Kharkiv National Medical University, department of internal medicine № 2 and clinical immunology and allergology, Kharkiv, Ukraine Introduction. Most of the patients with chronic obstructive pulmonary disease (COPD) and arterial hypertension (AH) have high risk of congestive heart failure (CHF). Today the attention of the scholars in many countries is drawn to the role of immune mechanisms in the development and progression of many diseases [1, 2]. Of great importance is to determine the role of specific immune response not only to the host tissues, but also to bacterial antigens, since they are able to make a direct damaging effect on the cells, resulting in the loss of their functional activity. The aim.We investigated whether remodeling of the left ventricle as a sign of CHF progression is associated with sensibilisation to bacterial antigens of Staphilococcus aureus (St. aureus), Streptococcus pneumoniae (Str. Pneumoniae) and Esherichia Coli (E. Coli). Material and methods. A total of 65 patients with CHF at COPD and AH were included in the study. The diagnosis of COPD was established according to GOLD 2014 guidelines [3]. Patients were subdivided into two groups according to the II and III class of congestive heart failure by NYHA. All the patients underwent echocardiography and laboratory investigation of leucocyte migration index in specific leucocyte migration inhibition test. Results. Among investigated patients an acceleration of leucocyte migration to E. Coli was recorded in 82%, to St. aureus – in 24 %, to Str. Pneumoniale – in 20%. The mean index of the reaction of specific leucocyte migration inhibition to E. Coli was 1.35 ± 0.001, to St. Aureus – 1.1 ± 0.001, Str. Pneumoniae – 1.17 ± 0.02. Correlation analysis by Spearman revealed the strong relationships between echocardiographic parameters of the left ventricle of the heart and the degree of patients sensibilisation to E. Coli. Thus index of specific leucocyte migration to E. Coli positively correlated with end diastolic volume of the left ventricle (r = 0.85), end diastolic diameters of the left ventricle (r = 0.83), End systolic volume of the left ventricle (r = 0.87) and end sistolic diameter of the left ventricle (r = 0.87) and negatively correlated with ejection fraction of the left ventricle (r = 0.74). While progression of CHF from NYHA II to NYHA III class there was an increase of leucocyte migration index to E. Coli on 31.0 % (p<0.05). There was not any significant differences in leucocyte migration indeces to St. Aureus and Str.Pneumoniae. Conclusions. The study showed a strong relationship between sensibilisation to E. Coli and left ventricle remodeling of the heart as well as with progression of congestive heart failure in patients with COPD and AH. Thus, the consumptions discussed in literature about intestinal bacteria involvement into the heart failure progression and cardiac remodeling are being supported by obtained facts, and demand further profound investigations. References. 1. Hogg, J.C., Chu, F., Utokaparch, S., Woods, R., Elliott, W.M., et al. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350: 2645–2653. 2. Cavaillès А, Brinchault-Rabin G, Adrien Dixmier et al. Comorbidities of COPD. Eur Respir Rev 2013;22(130):454-75. 3. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. http://www.goldcopd.org.